Read + Share
Fairclough S, Goodden J, Chumas P, Mathew R, et al. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time
to seizure freedom and rates of treatment failure. Epilepsia 2023;64:857-865.
PMID: 36636895
|
 |
|
Fairclough S, Goodden J, Chumas P, Mathew R, et al. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time
to seizure freedom and rates of treatment failure. Epilepsia 2023;64:857-865.
PMID: 36636895
|
|
|
|